You are here
Back to topJANUMET Drug Profile, 2024: JANUMET (metformin hydrochloride; sitagliptin phosphate) drug patents, FDA exclusivity, litigation, drug prices, sales (Paperback)
$249.00
Usually Ships in 1-5 Days
Description
JANUMET Drug Profile, 2024
This report focuses on JANUMET and covers the following critical aspects of this drug:
- United States patents
- Expired United States patents
- FDA Paragraph IV patent challenges
- District Court patent litigation
- Patent Trial and Appeal Board (PTAB) patent cases
- European supplementary protection certificates (SPCs)
- Clinical trials
- Drug prices
- Annual sales revenues
- Finished product suppliers
- Raw active pharmaceutical ingredient (API) sources